Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaping He

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Cell|April 17, 2012
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancerJames S Duncan, Martin C Whittle, Kazuhiro Nakamura, et al.
BMC Genomics|April 29, 2006
The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Cheng Fan, Daniel S Oh, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Cell Reports|September 24, 2013
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsShunqiang Li, Dong Shen, Jieya Shao, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Cell|April 17, 2012
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancerJames S Duncan, Martin C Whittle, Kazuhiro Nakamura, et al.
BMC Genomics|April 29, 2006
The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Cheng Fan, Daniel S Oh, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Cell Reports|September 24, 2013
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsShunqiang Li, Dong Shen, Jieya Shao, et al.
Pageof 6